Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Dermatol Surg ; 49(5): 483-488, 2023 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-36946749

RESUMEN

BACKGROUND: St. John's wort (SJW) contains hypericin, a powerful photosensitizer with antimicrobial and anti-inflammatory activities. OBJECTIVE: To compare the efficacy and safety of SJW-photodynamic therapy (PDT) with that of indole-3-acetic acid (IAA)-PDT for the treatment of acne and investigate the skin rejuvenating effects of SJW-PDT. MATERIALS AND METHODS: In vitro experiments were conducted to examine the generation of reactive oxygen species and the antimicrobial effects of SJW-PDT. In the prospective, double-blind, split-face, randomized study, 31 patients with facial acne were treated with SJW or IAA with simultaneous illumination of red light and green light. RESULTS: SJW produces free radicals with visible light irradiation, and the growth of Cutibacterium acnes and Staphylococcus aureus is significantly suppressed. One week after the last treatment, the acne lesion counts were significantly decreased in both groups (56.5% reduction in SJW, p < .001 vs 57.0% in IAA, p < .001). Significant reductions in sebum secretion, erythema index, roughness, and wrinkles were observed in both groups after the treatment. No side effects were observed. CONCLUSION: SJW-PDT is a simple, safe, and effective treatment option for acne that is also beneficial for skin rejuvenation.


Asunto(s)
Acné Vulgar , Hypericum , Fotoquimioterapia , Humanos , Acné Vulgar/tratamiento farmacológico , Fotoquimioterapia/efectos adversos , Extractos Vegetales/uso terapéutico , Estudios Prospectivos , Método Doble Ciego
2.
J Cosmet Dermatol ; 21(4): 1471-1476, 2022 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-34008912

RESUMEN

BACKGROUND: Recently, pulsed dye laser (PDL) combined with triamcinolone intralesional injection (TAILI) has been introduced for surgical scar prevention. However, little is known about this procedure's effectiveness in preventing hypertrophic scar following surgical scar removal. OBJECTIVES: This study aimed to evaluate the outcome of early intervention using PDL combined with TAILI after surgical removal of hypertrophic cesarean section (CS) scars. METHODS: The medical records of 35 patients who underwent early intervention using PDL and TAILI after removal of hypertrophic CS scars were retrospectively reviewed. The scars' average Vancouver Scar Scale (VSS) scores before scar removal and 3 months after the final treatment were compared. RESULTS: The patients received 4.23 treatments on average and were followed up for a mean period of 7.74 months. The mean final VSS was 3.11 ± 1.52 and was significantly lower than that of the previous VSS (9.29 ± 1.74, p = 0.000). VSS of the previous CS scar, and the presence or absence of keloid formation in other areas, was associated with treatment outcome (p = 0.003 and 0.008, respectively). CONCLUSIONS: Early intervention using PDL combined with TAILI could prevent the recurrence or progression of hypertrophic CS scarring after surgical scar removal.


Asunto(s)
Cicatriz Hipertrófica , Queloide , Láseres de Colorantes , Terapia por Luz de Baja Intensidad , Cesárea/efectos adversos , Cicatriz Hipertrófica/etiología , Cicatriz Hipertrófica/prevención & control , Femenino , Humanos , Inyecciones Intralesiones , Queloide/etiología , Queloide/patología , Queloide/terapia , Láseres de Colorantes/efectos adversos , Embarazo , Estudios Retrospectivos , Resultado del Tratamiento , Triamcinolona
3.
Artículo en Inglés | MEDLINE | ID: mdl-32595740

RESUMEN

BACKGROUND: Saline groundwater, collected from the east coast of Korea, has been shown to have protective effects against 2,4-dinitrochlorobenzene- (DNCB-) induced atopic dermatitis-like skin lesions in the murine model. OBJECTIVES: To determine the effects of saline groundwater solution baths as a treatment of mild-to-moderate atopic dermatitis. METHODS: Twenty-four subjects with mild-to-moderate atopic dermatitis were instructed to take a bath in saline groundwater solution for 20 minutes per day for two weeks. Evaluations were performed at baseline and week 2, including SCORing Atopic Dermatitis (SCORAD) index, corneometry, transepidermal water loss, visual analogue scale for pruritus, and collection of adverse events. RESULTS: Subjects showed significant improvement with respect to the SCORAD index, skin hydration, transepidermal water loss, and pruritus at week 2 when compared with the baseline. CONCLUSION: Baths in saline groundwater solution may be an alternative therapeutic strategy for treating atopic dermatitis.

4.
Acta Derm Venereol ; 99(3): 284-290, 2019 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-30460369

RESUMEN

The aim of this study was to evaluate changes in the skin surface microbiome in patients with atopic dermatitis during treatment. The effect of narrowband ultraviolet B phototherapy was also studied to determine the influence of exposure to ultraviolet. A total of 18 patients with atopic dermatitis were included in the study. Patients were divided into 2 groups based on treatment: 1 group treated with narrowband ultraviolet B phototherapy and topical corticosteroid, and the other group treated with topical corticosteroid only. Skin swabs and high-throughput sequencing of 16S ribosomal RNA bacterial genes were performed at 3 time-points. The microbial diversity of lesional skin increased greatly after treatment. The proportion of Staphylococcus aureus showed a significant positive correlation with eczema severity. In conclusion, a drastic increase in microbial diversity and decrease in S. aureus proportion were observed with eczema treatment. Narrowband ultraviolet B treatment did not exert additive effects on eczema improvement; however, it appeared to reduce the recurrence of eczema.


Asunto(s)
Corticoesteroides/administración & dosificación , Dermatitis Atópica/terapia , Microbiota/efectos de los fármacos , Microbiota/efectos de la radiación , Piel/efectos de los fármacos , Piel/efectos de la radiación , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/efectos de la radiación , Terapia Ultravioleta , Administración Cutánea , Adolescente , Corticoesteroides/efectos adversos , Adulto , Niño , Preescolar , Dermatitis Atópica/diagnóstico , Dermatitis Atópica/microbiología , Femenino , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Masculino , Recurrencia , Ribotipificación , Seúl , Piel/microbiología , Staphylococcus aureus/genética , Factores de Tiempo , Resultado del Tratamiento , Terapia Ultravioleta/efectos adversos , Adulto Joven
5.
J Dermatolog Treat ; 28(5): 447-451, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27786580

RESUMEN

PURPOSE: To characterize the risk factors of Korean patients for postinflammatory hyperpigmentation (PIH) during treatment of solar lentigines using a Q-switched 532-nm Nd: YAG (QS 532 NY) laser. MATERIALS AND METHODS: The present retrospective multicenter study was conducted at the dermatology clinics of five tertiary hospitals in Korea. Between October 2007 and January 2013, 516 patients were enrolled and reviewed for clinical features and factors associated with PIH. RESULTS: The overall incidence of PIH was 20.3%. We demonstrated that patients with erythematous lentigines presented with PIH more frequently compared with those without erythematous lentigines. Among several coexisting conditions, facial diffuse dyschromia was significantly associated with PIH. Furthermore, PIH occurred more frequently in patients with invisible pores and velvety skin. However, age, sex, Fitzpatrick skin's phototype and season of treatment showed little association with PIH. CONCLUSIONS: When a QS 532 NY laser is used to treat individuals with erythematous lentigines, invisible pores and velvety skin, and facial diffuse dyschromia, clinicians should be cautious and consider preventive measures.


Asunto(s)
Láseres de Estado Sólido/uso terapéutico , Lentigo/radioterapia , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Pueblo Asiatico , Femenino , Humanos , Hiperpigmentación/epidemiología , Hiperpigmentación/etiología , Incidencia , Láseres de Estado Sólido/efectos adversos , Terapia por Luz de Baja Intensidad , Masculino , Persona de Mediana Edad , República de Corea/epidemiología , Estudios Retrospectivos , Encuestas y Cuestionarios , Centros de Atención Terciaria , Adulto Joven
6.
J Cosmet Laser Ther ; 18(5): 293-5, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27064823

RESUMEN

Jet-M (Tav-Tech Ltd., Israel) is an instrument for skin resurfacing. When it sprays microdroplets of solution or shoots air on the skin, exfoliation and stretching of superficial layers can occur. Thus, it will increase percutaneous absorption of vitamins and other cosmetic agents. A cosmetic preparation containing copper-glycyl-L-histidyl-L-lysine, oligo-hyaluronic acid, rhodiolar extract, tranexamic acid, and ß-glucan was used with Jet-M in one patient. Anesthesia was not administered and there was no pain during the treatment. A male aged 59 years was treated once a week for 12 weeks. In the clinical photographs, wrinkles around the treated eye were greatly decreased. Skin biopsies were taken from treated and untreated areas. Hematoxylin and eosin and Masson's trichrome staining showed increased collagen production in the upper dermis. On the other hand, collagen IV production was slightly increased. Fibrillin-1 and procollagen type 1 were greatly increased and tropoelastin was also increased. There was no adverse effect during and after treatment.


Asunto(s)
Cosméticos/uso terapéutico , Cara , Envejecimiento de la Piel/efectos de los fármacos , Colágeno/metabolismo , Humanos , Ácido Hialurónico , Lisina , Masculino , Persona de Mediana Edad , Oligopéptidos , Compuestos Organometálicos , Rhodiola , Ácido Tranexámico , beta-Glucanos
7.
Oxid Med Cell Longev ; 2012: 819623, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22973468

RESUMEN

The skin is constantly exposed to environmental oxidative stress. Skin equivalent (SE) models are three-dimensional systems in which cell-cell or cell-matrix interactions can be investigated. In this study, the effects of vitamin C or plant extracts with high antioxidant activities were tested. There was no significant difference in the epidermal thickness, but the basal cells became cuboidal when vitamin C or plant extracts were supplemented. Furthermore, immunohistochemical staining showed linear and intense staining of α6 and ß1 integrin along the basement membrane in vitamin C or plant extract treated models. The p63 and PCNA were also stained. Results showed that the number of p63 and PCNA positive cells was higher in the vitamin C or plant extract treated models than in the control SEs. Although the relationship between oxidative stress and stem cells is not known, our results suggest that redox status affects the stemness and the proliferative potential of epidermal basal cells by modulating microenvironment to epidermal basal stem cells.


Asunto(s)
Antioxidantes/metabolismo , Piel/metabolismo , Ácido Ascórbico/farmacología , Técnicas de Cultivo de Célula , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Fibroblastos/citología , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Humanos , Integrina alfa6/metabolismo , Integrina beta1/metabolismo , Queratinocitos/citología , Queratinocitos/efectos de los fármacos , Queratinocitos/metabolismo , Oxidación-Reducción , Extractos Vegetales/farmacología , Antígeno Nuclear de Célula en Proliferación/metabolismo , Piel/patología , Factores de Transcripción/metabolismo , Proteínas Supresoras de Tumor/metabolismo
8.
J Dermatol ; 39(7): 608-12, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22506614

RESUMEN

Ultraviolet (UV) irradiation induces skin erythema, but it is not clear which factors have the greatest effects on UV sensitivity. Six healthy Korean adult men were enrolled and their melanin index (MI) and increment of erythema index (ΔEI) were measured. In each individual, 12 different sites were selected and 36 spots were irradiated with a single shot of monochromatic excimer laser with a dose of 350 mJ/cm(2) . The sites were categorized into three groups based on the cumulative sun exposure: UZ, unexposed zones; FEZ, frequently exposed zones; and IEZ, intermittently exposed zones. The sun exposure indexes (SEI) were also calculated based on previously described methods. ΔEI, MI and SEI were measured and calculated. The ΔEI of UZ was significantly higher than that of FEZ, but lower than that of IEZ. In general, there was a significant relationship between ΔEI and MI (R(2) = 0.135). However, IEZ did not show significant results. In contrast, there was a stronger relationship between ΔEI and SEI (R(2) = 0.344). Overall, the values were significantly higher for the SEI (0.541 [UZ], 0.281 [IEZ] and 0.228 [FEZ]) than for MI (0.311 [UZ], 0.011 [IEZ] and 0.073 [FEZ]). There were significant site variations in UV sensitivity along with skin pigmentation. In addition, significant differences were observed according to the exposure frequency. The SEI was found to be strongly correlated with UV sensitivity. These results suggest that the induced level of pigmentation above the constitutive level will be a better indicator for UV sensitivity than baseline MI.


Asunto(s)
Eritema/etiología , Láseres de Excímeros/efectos adversos , Pigmentación de la Piel/efectos de la radiación , Adulto , Pueblo Asiatico , Eritema/metabolismo , Humanos , Láseres de Excímeros/uso terapéutico , Terapia por Luz de Baja Intensidad/efectos adversos , Masculino , Melaninas/metabolismo , Persona de Mediana Edad , Tolerancia a Radiación/fisiología , República de Corea , Pigmentación de la Piel/fisiología , Luz Solar
9.
J Dermatol ; 35(8): 484-90, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18789067

RESUMEN

Etanercept is a fully humanized soluble tumor necrosis factor (TNF)-alpha receptor that competitively inhibits the interaction of TNF-alpha with cell-surface receptors. It was approved as monotherapy for psoriasis in the USA in 2004, but in Korea, no clinical reports on its use for psoriasis are available. We performed a retrospective analysis of 26 moderate-to-severe psoriasis patients who had been treated with etanercept. Patients received twice-weekly injections of 25 mg etanercept s.c. for at least 4 weeks. When the patients achieved a 50% reduction of the psoriasis area severity index (PASI 50) they received once-weekly injections, then biweekly injections were provided for maintenance. Patients were evaluated biweekly by clinical photographs and PASI scoring. Treatment efficacy was as follows. A PASI 75 was achieved in 14 patients (54%) and the mean number of injections before achieving a PASI 75 was 10 +/- 7.5. Patients whose initial PASI was less than 10 (iPASI < 10) showed an earlier response (2.6 +/- 1.3 weeks) and a higher PASI 75 rate (63%), than with iPASI > or = 10 (6.9 +/- 4.5 weeks, 50%). Eight patients (31%) received additional phototherapy or systemic therapy because of insufficient responses or for faster improvements and they were excluded in the efficacy evaluation. Adverse events were observed in eight patients (31%), but were not serious. This is the first report on the effectiveness of low-dose etanercept regimen on Asian psoriasis patients. Results in this study showed that low-dose etanercept therapy is effective for moderate-to-severe Asian psoriasis patients, and it may be a valuable treatment option even for relatively moderate psoriasis patients not responsive to conventional treatment. In addition, the medical cost was relatively low compared to that of the standard regimen for white patients.


Asunto(s)
Antiinflamatorios no Esteroideos/administración & dosificación , Inmunoglobulina G/administración & dosificación , Inmunosupresores/administración & dosificación , Psoriasis/tratamiento farmacológico , Receptores del Factor de Necrosis Tumoral/administración & dosificación , Adolescente , Adulto , Anciano , Pueblo Asiatico , Etanercept , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
10.
Dermatol Surg ; 33(10): 1228-33; discussion 1233, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17903156

RESUMEN

BACKGROUND: Recently, a demand for safe and effective treatment of acne has been increasing. Although visible light has attracted attention as a new option, the effect of red light alone has not yet been evaluated. OBJECTIVES: The objective was to assess the efficacy of red light phototherapy with a portable device in acne vulgaris. METHODS: Twenty-eight volunteers with mild to moderate acne were treated with portable red light-emitting devices in this split-face randomized trial. The right or left side of the face was randomized to treatment side and phototherapy was performed for 15 minutes twice a day for 8 weeks. Clinical photographs, lesion counts, and a visual analog scale (VAS) were used to assess each side of the face at baseline and Weeks 1, 2, 4, and 8, and a split-face comparison was performed. RESULTS: The percent improvement in noninflammatory and inflammatory lesion counts of the treated side was significant compared to the control side (p<.005). VAS decreased from 3.9 to 1.9 on the treatment side and the difference between the treatment and control sides was significant at Week 8 (p<.005). CONCLUSIONS: This study shows that red light phototherapy alone can be a new therapeutic option for acne vulgaris.


Asunto(s)
Acné Vulgar/terapia , Acné Vulgar/patología , Adulto , Femenino , Humanos , Masculino , Fototerapia/métodos , Índice de Severidad de la Enfermedad , Método Simple Ciego , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA